John Thompson
Vermögen: - $ am 30.06.2026
Vermögen: - $ am 30.06.2026
John Craig Thompson is currently Chief Executive Officer & Director at Cerevance, Inc. since 2022 and Independent Non-Executive Director at NervGen Pharma Corp.
since 2022.
Former roles include President, Chief Executive Officer & Director at Anthera Pharmaceuticals, Inc. from 2016 to 2018; President & Chief Executive Officer at Neurana Pharmaceuticals, Inc.; Independent Director at Esperion Therapeutics, Inc. from 2025 to 2026; Vice President-Marketing at Pfizer Inc. from 2003 to 2010; Chief Operating Officer at Tetraphase Pharmaceuticals, Inc. from 2014 to 2015; and Chief Commercial Officer at Trius Therapeutics, Inc. Education includes an MBA from the University of Notre Dame and an undergraduate degree from McMaster University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NERVGEN PHARMA CORP. -.--% | 16.05.2025 | 0 ( -.--% ) | - $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| NERVGEN PHARMA CORP. | Direktor/Vorstandsmitglied | 13.04.2022 |
Cerevance, Inc.
Cerevance, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Vorstandsvorsitzender | 01.04.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
| ESPERION THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 13.07.2026 |
| ANTHERA PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 30.06.2018 |
| TETRAPHASE PHARMACEUTICALS, INC. | Geschäftsführer | 31.12.2015 |
| PFIZER INC. | Vertrieb & Marketing | 01.01.2010 |
Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for muscle spasms | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Anthera Pharmaceuticals, Inc.
Anthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of medicines for patients with unmet medical needs | Health Technology |
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tetraphase Pharmaceuticals, Inc.
Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
McMaster University
McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
Cerevance, Inc.
Cerevance, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Health Technology |
Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for muscle spasms | Health Technology |
NervGen Pharma Corp.
NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen